Japanese Semiconductors Stock News

TSE:9104
TSE:9104Shipping

Elliott Pushes Mitsui O.S.K. Lines To Reassess Value And Capital Use

Elliott Investment Management publicly urged Mitsui O.S.K. Lines (TSE:9104) to pursue a more ambitious strategy. The activist investor is calling for an enhanced medium term plan and a premium market valuation for the company. Elliott signaled its intention to engage with management to seek changes it believes could increase shareholder value. Mitsui O.S.K. Lines is a major Japanese shipping group with exposure to global trade, energy transport, and logistics services. The sector is...
TSE:5019
TSE:5019Oil and Gas

Is It Too Late To Consider Idemitsu Kosan (TSE:5019) After Its Strong Recent Share Price Run?

Wondering whether Idemitsu KosanLtd at ¥1,488.5 is priced attractively or already reflects much of its story? This article walks through the key valuation angles to help you frame that question. The stock has moved 5.1% over the last 30 days and 26.2% year to date, with a 33.2% return over the past year and very large gains over 3 and 5 years. This naturally raises questions about how the current price compares with its fundamentals and risks. Recent coverage of Idemitsu KosanLtd has focused...
TSE:9719
TSE:9719IT

How Investors Are Reacting To SCSK (TSE:9719) Being Removed From The FTSE All-World Index

In March 2026, SCSK Corporation (TSE:9719) was removed from the FTSE All-World Index (USD), marking a change in its index inclusion status. This index removal can matter for investors because it may prompt portfolio rebalancing by index-tracking funds and shift how the stock is positioned in global portfolios. We will now look at how SCSK’s removal from the FTSE All-World Index may influence its broader investment narrative for investors. Invest in the nuclear renaissance through our list...
TSE:8473
TSE:8473Capital Markets

Does SBI Holdings (TSE:8473) Higher Dividend Signal Evolving Capital Priorities Or Strategy Shift?

Earlier in March 2026, SBI Holdings’ board approved a revision to its year-end dividend forecast to ¥75 per share, reflecting profit levels in its Financial Services Business, and later met again to consider converting a second-tier subsidiary into a direct subsidiary. The higher dividend forecast, equivalent to ¥150 per share before the stock split and ¥10 above the prior year, highlights management’s willingness to return more cash to shareholders while potentially reshaping the group...
TSE:3391
TSE:3391Consumer Retailing

Tsuruha Holdings (TSE:3391) Valuation Check After February 2026 Sales And Store Update

Why the latest monthly update matters for Tsuruha Holdings Tsuruha Holdings (TSE:3391) has released its February 2026 consolidated sales update, showing all store net sales year-on-year (YoY) growth of 4.8% and existing store net sales YoY growth of 4.0%, alongside 12 openings and 17 closures. See our latest analysis for Tsuruha Holdings. The latest monthly sales growth comes as Tsuruha Holdings’ share price has a 1 day share price return of 3.25%, but a 30 day share price return of 7.79%...
TSE:4502
TSE:4502Pharmaceuticals

Does Takeda Pharmaceutical (TSE:4502) Still Offer Value After Its 33.7% One-Year Rally?

For investors considering whether Takeda Pharmaceutical at ¥5,800 represents fair value or a potential bargain, this article breaks down the key signals behind the share price. The stock has delivered a 33.7% return over the last year and 18.0% year to date, even though the last 7 days show a 1.2% decline and the last 30 days are roughly flat at 0.2%. Recent coverage has focused on Takeda Pharmaceutical in the context of broader healthcare and pharmaceutical sector themes. These themes can...